Skip to main content
Top
Published in: Tumor Biology 6/2013

Open Access 01-12-2013 | Research Article

Clinical implications of cancer stem cell-like side population cells in human laryngeal cancer

Authors: Dan Yu, Chunshun Jin, Yan Liu, Jingpu Yang, Yin Zhao, Haitao Wang, Xue Zhao, Jinzhang Cheng, Xueshibojie Liu, Caigang Liu

Published in: Tumor Biology | Issue 6/2013

Login to get access

Abstract

In this study, we try to detect and isolate the cancer stem cell-like side population cells (SP) from the laryngeal carcinoma cell line and primary laryngeal carcinoma and explore the clinical implications of SP cells in laryngeal carcinoma. The SP cells and non-side population cells (NSP) cells were sorted by Hoechst 33342 through FACS. The proliferation capacity, invasion ability, migration ability, and tumorigenic activity of the SP cells were evaluated. In addition, the association between the SP cells ratio and the prognostic factors of laryngeal cancer was analyzed. As a result, the percentage of the SP cells in Hep-2 cells was 5.1 %. The SP cells depicted float colonies, but the NSP cells failed to generate the typical cell spheres. The clone formation ratios were 47.47 ± 10.20 % vs. 4.98 ± 1.41 % in the flat plates and 46.82 ± 5.67 % vs. 12.53 ± 3.51 % in the soft agar for SP and NSP cells (P = 0.01 and 0.01). The SP cells depicted a higher migrating potency than the NSP cells in both the transwell assay and scarification test (all P < 0.05). The matrigel invasion assay showed that the artificial basement membrane penetration rate of SP cells was 39.04 ± 4.78 %, which was higher than 25.16 ± 4.63 % of the NSP cells (P < 0.05). Only 103 SP cells were able to form tumors in mice, whereas 104 NSP cells failed to form tumors. The SP cells were correlated with the differentiation, lymph node metastasis, and clinical stage of the laryngeal cancers. In conclusion, SP cells may be a potential prognostic factor of laryngeal cancer.
Literature
1.
go back to reference Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975–2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003;95(17):1276–99.PubMedCrossRef Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975–2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003;95(17):1276–99.PubMedCrossRef
2.
go back to reference Shah PK, Shah KK, Karakousis GC, Reinke CE, Kelz RR, Fraker DL. Regional recurrence after lymphadenectomy for clinically evident lymph node metastases from papillary thyroid cancer: a cohort study. Ann Surg Oncol. 2012;19(5):1453–9.PubMedCrossRef Shah PK, Shah KK, Karakousis GC, Reinke CE, Kelz RR, Fraker DL. Regional recurrence after lymphadenectomy for clinically evident lymph node metastases from papillary thyroid cancer: a cohort study. Ann Surg Oncol. 2012;19(5):1453–9.PubMedCrossRef
3.
go back to reference Baek SK, Jung KY, Kang SM, et al. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma. Thyroid. 2010;20(2):147–52.PubMedCrossRef Baek SK, Jung KY, Kang SM, et al. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma. Thyroid. 2010;20(2):147–52.PubMedCrossRef
4.
go back to reference Behbod F, Rosen JM. Will cancer stem cells provide new therapeutic targets? Carcinogenesis. 2005;26(4):703–11.PubMedCrossRef Behbod F, Rosen JM. Will cancer stem cells provide new therapeutic targets? Carcinogenesis. 2005;26(4):703–11.PubMedCrossRef
5.
6.
go back to reference Soltysova A, Altanerova V, Altaner C. Cancer stem cells. Neoplasma. 2005;52(6):435–40.PubMed Soltysova A, Altanerova V, Altaner C. Cancer stem cells. Neoplasma. 2005;52(6):435–40.PubMed
7.
go back to reference Wang J, Guo LP, Chen LZ, Zeng YX, Lu SH. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res. 2007;67(8):3716–24.PubMedCrossRef Wang J, Guo LP, Chen LZ, Zeng YX, Lu SH. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res. 2007;67(8):3716–24.PubMedCrossRef
8.
go back to reference Zhang Q, Shi S, Yen Y, Brown J, Ta JQ, Le AD. A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett. 2010;289(2):151–60.PubMedCrossRef Zhang Q, Shi S, Yen Y, Brown J, Ta JQ, Le AD. A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett. 2010;289(2):151–60.PubMedCrossRef
9.
go back to reference Zhou Y, Zhou N, Fang W, Huo J. Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer. Diagn Pathol. 2010;5:58.PubMedCrossRef Zhou Y, Zhou N, Fang W, Huo J. Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer. Diagn Pathol. 2010;5:58.PubMedCrossRef
10.
go back to reference Chung SY, Lee JS, Lee H, Park SH, Kim SJ, Ryu HS. Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma. Acta Cytol. 2013;57(3):252–8.PubMedCrossRef Chung SY, Lee JS, Lee H, Park SH, Kim SJ, Ryu HS. Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma. Acta Cytol. 2013;57(3):252–8.PubMedCrossRef
11.
go back to reference Liu C, Luo Y, Liu X, Lu P, Zhao Z. Clinical implications of CD44+/CD24− tumor cell ratio in breast cancer. Cancer Biother Radiopharm. 2012;27(5):324–8.PubMedCrossRef Liu C, Luo Y, Liu X, Lu P, Zhao Z. Clinical implications of CD44+/CD24− tumor cell ratio in breast cancer. Cancer Biother Radiopharm. 2012;27(5):324–8.PubMedCrossRef
12.
go back to reference Sell S. Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol. 2004;51(1):1–28.PubMedCrossRef Sell S. Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol. 2004;51(1):1–28.PubMedCrossRef
13.
go back to reference Xu D, Xu H, Ren Y, et al. Cancer stem cell-related gene periostin: a novel prognostic marker for breast cancer. PLoS One. 2012;7(10):e46670.PubMedCrossRef Xu D, Xu H, Ren Y, et al. Cancer stem cell-related gene periostin: a novel prognostic marker for breast cancer. PLoS One. 2012;7(10):e46670.PubMedCrossRef
14.
go back to reference Liu CG, Lu Y, Wang BB, et al. Clinical implications of stem cell gene Oct-4 expression in breast cancer. Ann Surg. 2011;253(6):1165–71.PubMedCrossRef Liu CG, Lu Y, Wang BB, et al. Clinical implications of stem cell gene Oct-4 expression in breast cancer. Ann Surg. 2011;253(6):1165–71.PubMedCrossRef
15.
go back to reference Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2− cancer cells are similarly tumorigenic. Cancer Res. 2005;65(14):6207–19.PubMedCrossRef Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2− cancer cells are similarly tumorigenic. Cancer Res. 2005;65(14):6207–19.PubMedCrossRef
16.
go back to reference Challen GA, Little MH. A side order of stem cells: the SP phenotype. Stem Cells. 2006;24(1):3–12.PubMedCrossRef Challen GA, Little MH. A side order of stem cells: the SP phenotype. Stem Cells. 2006;24(1):3–12.PubMedCrossRef
17.
go back to reference Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A. 2007;104(3):973–8.PubMedCrossRef Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A. 2007;104(3):973–8.PubMedCrossRef
Metadata
Title
Clinical implications of cancer stem cell-like side population cells in human laryngeal cancer
Authors
Dan Yu
Chunshun Jin
Yan Liu
Jingpu Yang
Yin Zhao
Haitao Wang
Xue Zhao
Jinzhang Cheng
Xueshibojie Liu
Caigang Liu
Publication date
01-12-2013
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 6/2013
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-0941-6

Other articles of this Issue 6/2013

Tumor Biology 6/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine